In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...

Researchers built an immune-aging clock from 1.2 million cells, revealing T cells as key indicators of immune aging. They ...

As a wave of plans for low Earth orbit (LEO) broadband constellations enters the market, a 63-year-old former NASA Branch Chief and Google executive is betting on narrow beams, higher frequencies and ...

Can your gut bacteria control your stress? Microbial diversity and short-chain fatty acids are linked to acute cortisol ...

How does the placebo effect work? A new study identifies the vlPAG brain region and endogenous opioid signaling as the keys to expectancy-driven pain relief.

Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has started to ship engineering samples of “TB9M030FG,” the ...

A new study from China reports a breakthrough metasurface-enabled terahertz (THz) imaging and spectroscopy platform that ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune ...

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ...

Explore 25 rare brain abilities only a tiny fraction of people have, from tetrachromacy to echolocation. Uncover the ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic ...

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track de ...